Your browser doesn't support javascript.
loading
Aggressive prolactinomas responsive to temozolomide treatment: Report of two cases.
Davoudi, Zahra; Hallajnejad, Mohammad; Jamali, Elena; Honarvar, Mohammadjavad.
Afiliação
  • Davoudi Z; Department of Endocrinology Skull Base Research Center of Shahid Beheshti University of Medical Sciences Tehran Iran.
  • Hallajnejad M; Department of Neurosurgery Skull Base Research Center of Shahid Beheshti University of Medical Sciences Tehran Iran.
  • Jamali E; Department of Pathology, Loghman Hakim Medical Center Shahid Beheshti University of Medical Sciences Tehran Iran.
  • Honarvar M; Endocrine Research Center, Research Institute for Endocrine Sciences Shahid Beheshti University of Medical Sciences Tehran Iran.
Clin Case Rep ; 10(7): e6087, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35865778
ABSTRACT
Refractory aggressive prolactinomas are detected after the unresponsiveness to conventional therapies. We report two cases that underwent temozolomide treatment and have been in near-complete remission ever since. We suggest the pathology techniques for earlier detection and, subsequently, treatment with temozolomide to reduce morbidities and better respond to therapy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2022 Tipo de documento: Article